Opuntia humifusa stems rich in quercetin and isorhamnetin alleviate insulin resistance in high-fat diet-fed rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVESObesity, characterized by abnormal fat accumulation and metabolic disturbances, presents a significant health challenge. Opuntia humifusa Raf., commonly known as Korean Cheonnyuncho, is rich in various beneficial compounds and has demonstrated antioxidant and anti-inflammatory effects. However, its potential impact on glucose and lipid metabolism, particularly in obese rats, remains unexplored. We aimed to investigate whether O. humifusa stems and fruits could beneficially alter glucose metabolism and lipid profiles in a rat model of high-fat diet (HFD)-induced obesity. MATERIALS/METHODSThirty-two rats were allocated into 4 groups: normal diet (NF), HFD control (HF), HFD treated with 2% O. humifusa stems (HF-OS), and HFD treated with 2% O. humifusa fruits (HF-OF). Experimental diets were administered for 6 weeks. At the end of the treatment, liver and fat tissues were isolated, and serum was collected for biochemical analysis. The major flavonoid from O. humifusa stems and fruits was identified and quantified. RESULTSAfter 6 weeks of treatment, the serum fasting glucose concentration in the HF-OS group was significantly lower than that in the HF group. Serum fasting insulin concentrations in both HF-OS and HF-OF groups tended to be lower than those in the HF group, indicating a significant improvement in insulin sensitivity in the HF-OS group. Additionally, the HF-OS group exhibited a tendency towards the restoration of adiponectin levels to that of the NF group. CONCLUSIONThe 2% O. humifusa stems contain abundant quercetin and isorhamnetin, which alter fasting blood glucose levels in rats fed a HFD, leading to a favorable improvement in insulin resistance.
Abstract
BACKGROUND/OBJECTIVESObesity, characterized by abnormal fat accumulation and metabolic disturbances, presents a significant health challenge. Opuntia humifusa Raf., commonly known as Korean Cheonnyuncho, is rich in various beneficial compounds and has demonstrated antioxidant and anti-inflammatory effects. However, its potential impact on glucose and lipid metabolism, particularly in obese rats, remains unexplored. We aimed to investigate whether O. humifusa stems and fruits could beneficially alter glucose metabolism and lipid profiles in a rat model of high-fat diet (HFD)-induced obesity. MATERIALS/METHODSThirty-two rats were allocated into 4 groups: normal diet (NF), HFD control (HF), HFD treated with 2% O. humifusa stems (HF-OS), and HFD treated with 2% O. humifusa fruits (HF-OF). Experimental diets were administered for 6 weeks. At the end of the treatment, liver and fat tissues were isolated, and serum was collected for biochemical analysis. The major flavonoid from O. humifusa stems and fruits was identified and quantified. RESULTSAfter 6 weeks of treatment, the serum fasting glucose concentration in the HF-OS group was significantly lower than that in the HF group. Serum fasting insulin concentrations in both HF-OS and HF-OF groups tended to be lower than those in the HF group, indicating a significant improvement in insulin sensitivity in the HF-OS group. Additionally, the HF-OS group exhibited a tendency towards the restoration of adiponectin levels to that of the NF group. CONCLUSIONThe 2% O. humifusa stems contain abundant quercetin and isorhamnetin, which alter fasting blood glucose levels in rats fed a HFD, leading to a favorable improvement in insulin resistance.
참고문헌 (52)
- Boutari C, "A 2022 update on the epidemiology of obesity and a call to action : as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on", Metabolism, 133, pp.155217~ (2022)
- Hill JO, "Energy balance and obesity", Circulation, 126, pp.126~132 (2012)
- Woolcott OO, "Prevalence trends in obesity defined by the relative fat mass(RFM)index among adults in the United States : 1999–2018", Metabolism, 128, pp.155027~ (2022)
- Kivimäki M, "Body-mass index and risk of obesity-related complex multimorbidity : an observational multicohort study", Lancet Diabetes Endocrinol, 10, pp.253~263 (2022)
- Petrie JR, "Diabetes, hypertension, and cardiovascular disease : clinical insights and vascular mechanisms", Can J Cardiol, 34, pp.575~584 (2018)
- Emerging Risk Factors Collaboration, "Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease : collaborative analysis of 58 prospective studies", Lancet, 377, pp.1085~1095 (2011)
- Mayor S, "Being overweight may raise risk of eight more cancers, review finds", BMJ, 354, pp.i4650~ (2016)
- Fabbrini E, "Obesity and nonalcoholic fatty liver disease : biochemical, metabolic, and clinical implications", Hepatology, 51, pp.679~689 (2010)
- Francque SM, "NAFLD prevalence and severity in overweight and obese populations", Lancet Gastroenterol Hepatol, 8, pp.2~3 (2023)
- Tyrrell J, "Using genetics to understand the causal influence of higher BMI on depression", Int J Epidemiol, 48, pp.834~848 (2019)
- Mili N, "Obesity, metabolic syndrome, and cancer : pathophysiological and therapeutic associations", Endocrine, 74, pp.478~497 (2021)
- Taylor R, "Pathogenesis of type 2 diabetes : tracing the reverse route from cure to cause", Diabetologia, 51, pp.1781~1789 (2008)
- Larsson SC, "Causal role of high body mass index in multiple chronic diseases : a systematic review and meta-analysis of Mendelian randomization studies", BMC Med, 19, pp.320~ (2021)
- Kotsis V, "Obesity and cardiovascular risk : a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity : part A : mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment", J Hypertens, 36, pp.1427~1440 (2018)
- Flegal KM, "Association of all-cause mortality with overweight and obesity using standard body mass index categories : a systematic review and meta-analysis", JAMA, 309, pp.71~82 (2013)
- Jia H, "Trends in quality-adjusted life-years lost contributed by smoking and obesity", Am J Prev Med, 38, pp.138~144 (2010)
- Kolotkin RL, "Quality of life and obesity", Obes Rev, 2, pp.219~229 (2001)
- Finkelstein EA, "Annual medical spending attributable to obesity: payer-and service-specific estimates", Health Aff(Millwood), 28, pp.822~831 (2009)
- Okunogbe A, "Economic impacts of overweight and obesity : current and future estimates for eight countries", BMJ Glob Health, 6, pp.e006351~ (2021)
- Okunogbe A, "Economic impacts of overweight and obesity : current and future estimates for 161 countries", BMJ Glob Health, 7, pp.e009773~ (2022)
- Anderson EF, "The Cactus Family" (2001), Timber Press
- Goldstein G, "Water relations and low-temperature acclimation for cactus species varying in freezing tolerance", Plant Physiol, 104, pp.675~681 (1994)
- Del Socorro Santos Díaz M, "Opuntia spp. : characterization and benefits in chronic diseases", Oxid Med Cell Longev, 2017, pp.8634249~ (2017)
- Yoon JA, "Total polyphenol and flavonoid of fruit extract of Opuntia humifusa and its inhibitory effect on the growth of MCF-7 human breast cancer cells", J Korean Soc Food Sci Nutr, 38, pp.1679~1684 (2009)
- Yoon JA, "Nutrients contents in different parts of pickly pear(Opuntia humifusa)and possible anti-breast cancer effect", J Korean Soc Food Sci Nutr, 22, pp.485~491 (2009)
- Hahm SW, "Opuntia humifusa stems lower blood glucose and cholesterol levels in streptozotocin-induced diabetic rats", Nutr Res, 31, pp.479~487 (2011)
- Cho JY, "Radical scavenging and anti-inflammatory activity of extracts from Opuntia humifusa Raf", J Pharm Pharmacol, 58, pp.113~119 (2006)
- Kim J, "Chemopreventive effect of cactus(Opuntia humifusa)extracts : radical scavenging activity, pro-apoptosis, and anti-inflammatory effect in human colon(SW480)and breast cancer(MCF7)cells", Food Funct, 4, pp.681~688 (2013)
- Yeo JY, "Anti-inflammatory effect of neo-lignan isoamericanin A via suppression of NF-κB in liposaccharide-stimulated RAW 264. 7 cells", Trop J Pharm Res, 19, pp.1857~1862 (2020)
- Hahm SW, "Opuntia humifusa partitioned extracts inhibit the growth of U87MG human glioblastoma cells", Plant Foods Hum Nutr, 65, pp.247~252 (2010)
- Lee SH, "Phenolic profiling and quantitative determination of common sage(Salvia plebeia R. Br. )by UPLC-DAD-QTOF", MS, 2018, pp.244, 1637~1646
- Kim HW, "Identification and quantification of hydroxybenzoyl and hydroxycinnamoyl derivatives from Korean sweet potato cultivars by UPLC-DAD-QToF", MS, 2021, pp.100, 103905~
- Mosser RE, "High-fat diet-induced β-cell proliferation occurs prior to insulin resistance in C57Bl", 6J male mice, 2015, pp.308, E573~82
- Antunes LC, "Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats", Arch Endocrinol Metab, 60, pp.138~142 (2016)
- Nemati M, "High-fat diet effects on metabolic responses to chronic stress", Arch Physiol Biochem, 123, pp.182~191 (2017)
- Kang J, "Effect of Opuntia humifusa supplementation and acute exercise on insulin sensitivity and associations with PPAR-γ and PGC-1α protein expression in skeletal muscle of rats", Int J Mol Sci, 14, pp.7140~7154 (2013)
- Chandran M, "Adiponectin : more than just another fat cell hormone", Diabetes Care, 26, pp.2442~2450 (2003)
- Menzaghi C, "Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease", Diabetes, 56, pp.1198~1209 (2007)
- Katsiki N, "Adiponectin, lipids and atherosclerosis", Curr Opin Lipidol, 28, pp.347~354 (2017)
- Tschritter O, "Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism", Diabetes, 52, pp.239~243 (2003)
- Liu C, "Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes : a systematic review and meta-analysis", Cytokine, 86, pp.100~109 (2016)
- Kim EK, "Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor κB activation", Pancreas, 35, pp.e1~9 (2007)
- Ouchi N, "Adiponectin as an anti-inflammatory factor", Clin Chim Acta, 380, pp.24~30 (2007)
- Jung EY, "Hypocholesterol effect of Opuntia humifusa extract on high cholesterol diet-induced hypercholesterolemic rats", J Korean Soc Food Sci Nutr, 43, pp.485~490 (2014)
- Baz L, "Lycopene improves metabolic disorders and liver injury induced by a hight-fat diet in obese rats", Molecules, 27, pp.7736~ (2022)
- Park MK, "Hepatoprotective effect of Cheonnyuncho(Opuntia humifusa)extract in rats treated carbon tetrachloride", Korean J Food Sci Technol, 37, pp.822~826 (2005)
- Boucher P, "Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans", Lipids, 33, pp.1177~1186 (1998)
- Jiang H, "Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes", Sci Rep, 9, pp.2690~ (2019)
- Kobori M, "Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57", BL6J mice, 2011, pp.55, 530~540
- Matboli M, "New insight into the role of isorhamnetin as a regulator of insulin signaling pathway in type 2 diabetes mellitus rat model : molecular and computational approach", Biomed Pharmacother, 135, pp.111176~ (2021)
- Tundis R, "Inhibitory effects on the digestive enzyme α-amylase of three Salsola species(Chenopodiaceae)in vitro", Pharmazie, 62, pp.473~475 (2007)
- Yang EI, "Biological activities of water-soluble polysaccharides from Opuntia humifusa stem in high-fat-diet-fed mice", J Food Biochem, 43, pp.e12806~ (2019)